22 biotech companies that will likely get bought as M&A heats up this summer

Advertisement
22 biotech companies that will likely get bought as M&A heats up this summer
A research scientist working at Arrowhead PharmaceuticalsArrowhead

Hello,

Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let's get to it...

Advertisement

Top biotech analysts say M&A is set to heat up this summer. Here are the 22 drug companies that are likely to get bought.

See the full list>>


22 biotech companies that will likely get bought as M&A heats up this summer
Dame Valerie Adams Receives Covid-19 VaccinationDave Rowland/Getty Images

Experts explain why the mRNA tech that revolutionized COVID-19 vaccines could be the answer to incurable diseases, heart attacks, and even snake bites: 'The possibilities are endless'

Get the full story>>


22 biotech companies that will likely get bought as M&A heats up this summer
Scientific illustration of Candida auris.Kateryna Kon/Getty Image

Deadly fungi are becoming drug-resistant, and it's the next big public health threat, experts say

Here's what's at stake>>

Advertisement


More stories we're reading:


- Lydia

{{}}